
NeoPrediX
Enhance & personalize healthcare in maternal and neonatal care.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
* | N/A | Early VC | |
Total Funding | 000k |
Related Content
NeoPrediX is an innovative startup in the medical technology software sector, spun off from the University of Basel. The company specializes in developing clinical decision support software aimed at enhancing perinatal and neonatal care. NeoPrediX's core product helps clinicians identify the risk of newborn diseases early, enabling more informed care decisions. This not only improves patient safety but also reduces costs for hospitals and patients, and helps mitigate clinician burnout. The company primarily serves hospitals and healthcare providers, operating in the medical technology market. NeoPrediX's business model revolves around selling its software solutions to healthcare institutions, generating revenue through software licensing and service fees. The company's mission is to support individualized healthcare early in life by transforming patient data into scientifically validated forecasts that aid clinical decision-making.
Keywords: neonatal care, clinical decision support, early disease identification, perinatal care, medical technology, healthcare software, patient safety, cost reduction, clinician support, individualized healthcare.